Press release
Oncolytic Virus Therapies Market Size 2023: Global Report, Industry Analysis and Trends by 2028
Oncolytic Virus Therapies Market
Oncolytic virus therapies are a type of immunotherapy that harnesses the power of viruses to selectively infect and destroy cancer cells. These therapies utilize a range of natural and genetically modified viruses, including herpes simplex, vaccinia, adenovirus, reovirus, picornavirus, and more. By infecting cancer cells, oncolytic viruses activate danger signals that stimulate an immune response and target solid tumors, melanoma, and unresectable lesions. They can effectively eliminate tumors by specifically attacking and destroying the malignant cells while sparing healthy tissue. In contrast to traditional chemotherapy, oncolytic virus therapies are non-toxic and offer enhanced efficacy, leading to improved survival rates for cancer patients. This makes them a promising treatment option in the field of oncology. Oncolytic virus therapies are extensively utilized in hospitals, clinics, and cancer research institutes, where they are employed to advance patient care, explore new treatment strategies, and conduct clinical trials.
How Big Is the Oncolytic Virus Therapies Market?
The global oncolytic virus therapies market size reached US$ 130.4 Million in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 492.6 Million by 2028 exhibiting a CAGR of 20.90% during 2023-2028.
Read Full Report: https://www.imarcgroup.com/oncolytic-virus-therapies-market
Oncolytic Virus Therapies Market Trends and Drivers:
The oncolytic virus therapies market is experiencing significant growth driven by several factors. One key factor is the widespread adoption of these therapies for treating various cancers, including glioblastoma, breast, lung, and prostate cancers. These therapies possess potent anti-tumor properties and the ability to precisely target tumors while minimizing harm to surrounding healthy tissues, making them highly effective in cancer treatment. Additionally, there is an increasing demand for oncolytic virus therapies in managing different types of melanomas, such as hematological malignancies, lymphoma, leukemia, and myeloma, which further contributes to market growth. Moreover, patients' growing concerns about the potential negative health impacts of conventional cancer treatments like surgery, radiation therapy, chemotherapy, and immunotherapy are driving the demand for alternative options like oncolytic virus therapies. These therapies offer a promising and less invasive treatment approach. Furthermore, the increasing number of advanced clinical studies focusing on oncolytic viruses, including herpesvirus, adenovirus, and vaccinia, that have reached the final stages and demonstrated promising experimental results, positively influences the global market. The findings from these studies contribute to the growing body of evidence supporting the effectiveness of oncolytic virus therapies. Additionally, the rising need for advanced treatments and novel therapeutics, along with the launch of initiatives by government bodies to raise awareness about different causes of cancer and promote early diagnosis, are expected to drive the oncolytic virus therapies market. Overall, the oncolytic virus therapies market is propelled by the adoption of these therapies for various cancers, increasing patient demand for alternative treatments, advancements in clinical studies, and supportive initiatives by government organizations.
Get Your Free Sample PDF Report: https://www.imarcgroup.com/oncolytic-virus-therapies-market/requestsample
What Is Included In Market Segmentation?
The report has been segmented the market into following categories:
Breakup by Virus Type:
Genetically Engineered Oncolytic Viruses
Herpes Simplex Virus
Adenovirus
Vaccinia Virus
Oncolytic Wild-Type Viruses
Reovirus
Newcastle Disease Virus
Vesicular Stomatitis Virus
Breakup by Application:
Solid Tumors
Breast Cancer
Prostate Cancer
Lung Cancer
Glioblastoma
Melanoma
Hematological Malignancies
Lymphoma
Leukemia
Myeloma
Breakup by End Use:
Hospitals
Specialty Clinics
Cancer Research Institute
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report provides a comprehensive analysis of the industry key players listed below:
Amgen Inc., Dnatrix Inc., Genelux Corporation, Lokon Pharma AB, Replimune Group Inc., Rigvir Ltd., Sorrento Therapeutics, Takara Bio Inc. (Takara Holdings Inc.), Targovax, TILT Biotherapeutics Ltd, Transgene SA and Vyriad.
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=6592&flag=C
Related Posts:
Beer Packaging Market Report 2023-2028: https://www.digitaljournal.com/pr/news/imarc/beer-packaging-market-size-is-projected-to-reach-us-30-0-billion-by-2028
Smart Insulin Pens Market Report 2023-2028: https://www.digitaljournal.com/pr/news/imarc/smart-insulin-pens-market-size-is-projected-to-reach-us-193-2-million-by-2028
Online Lottery Market Report 2023-2028: https://www.digitaljournal.com/pr/news/imarc/online-lottery-market-size-is-projected-to-reach-us-15-1-billion-by-2028
Hdpe Pipes Market Report 2023-2028: https://www.digitaljournal.com/pr/news/imarc/hdpe-pipes-market-size-is-projected-to-reach-us-32-2-billion-by-2028
Aerospace Engineering Services Outsourcing Market Report 2023-2028: https://www.digitaljournal.com/pr/news/imarc/aerospace-engineering-services-outsourcing-market-size-is-projected-to-reach-us-256-6-billion-by-2028
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Therapies Market Size 2023: Global Report, Industry Analysis and Trends by 2028 here
News-ID: 3126127 • Views: …
More Releases from IMARC Group
Automotive Control Cables Manufacturing Plant Setup Report 2025: Machinery, Raw …
Automotive control cables are essential components used to transmit mechanical force in vehicles, enabling the smooth operation of various systems such as brakes, clutches, accelerators, gear shifts, and seating mechanisms. These cables are designed for durability, flexibility, and high performance under diverse driving conditions. Their demand is directly linked to the growth of the automotive industry, aftermarket sales, and increasing consumer preference for enhanced driving comfort and safety.
Setting up an…
Halal Cosmetics Market Size, Trends, Key Players, Opportunity and Forecast 2025- …
IMARC Group, a leading market research company, has recently released a report titled "Halal Cosmetics Market Size, Share, Trends and Forecast by Type, Distribution Channel, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global halal cosmetics market size, trends, share and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Halal Cosmetics Market Highlights:
• Halal Cosmetics Market…
Comprehensive Castor Oil Processing Plant Project Report 2025: Setup Guide, Econ …
Castor oil is a versatile vegetable oil extracted from the seeds of the Ricinus communis plant. It is widely used in pharmaceuticals, cosmetics, food processing, lubricants, paints, coatings, and biodiesel production owing to its unique chemical properties, including high ricinoleic acid content. Castor oil derivatives also serve as key raw materials in the polymer, chemical, and industrial sectors.
Establishing a castor oil processing plant involves steps such as seed cleaning, dehulling,…
Honey Processing Plant Report 2025: Capital Investment, Operating Expenses and M …
Honey is a natural sweetener produced by honeybees and is valued for its nutritional, medicinal, and industrial applications. It contains antioxidants, enzymes, vitamins, and minerals that make it a popular ingredient in food and beverages, pharmaceuticals, cosmetics, and personal care products. Processed honey is widely consumed as a sweetener, used in bakery and confectionery items, beverages, dietary supplements, and skincare formulations.
Setting up a honey processing plant involves operations such as…
More Releases for Virus
Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817
The outbreak of Zika virus infection in Latin…
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of…
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
